Results 141 to 150 of about 1,313 (182)

Extracorporeal photochemotherapy in mycosis fungoides

Transfusion Clinique et Biologique, 2017
Extracorporeal photo-chemotherapy (ECP, photopheresis) is an approved treatment modality for mycosis fungoides (MF). Our aim is to present our ECP data for MF.We retrospectively evaluated 50 MF patients who received ECP for clinical activity, toxicity, and response and outcome rates, and we compared these with combination therapies.The overall response
E. Atilla, P.A. Atilla, S.C. Bozdag, M.K. Yuksel, S.K. Toprak, P. Topcuoglu, B.N. Akay, H. Sanli, H. Akan, T. Demirer, M. Beksac, O. Arslan, M. Ozcan, G. Gurman, O. Ilhan   +14 more
openaire   +3 more sources

Transimmunization and the evolution of extracorporeal photochemotherapy

Transfusion and Apheresis Science, 2002
We are now aware that extracorporeal photopheresis (ECP) - in which a patient's leukocytes are isolated, passed through an ultrathin clear plastic plate, and exposed to 8-methoxypsoralen (8-MOP) and ultraviolet A light prior to reinfusion - is a simple and efficient dendritic cell (DC) therapy and the first FDA approved selective immunotherapy for ...
Carole L. Berger, Jeffrey S. Schechner, Earl J. Glusac, Richard L. Edelson, Michael Girardi   +4 more
openaire   +3 more sources

Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis

Journal of the European Academy of Dermatology and Venereology, 2003
ABSTRACTBackground Eosinophilic fasciitis (EF) is a rare connective tissue disorder characterized clinically by symmetrical swelling, induration and thickening of the skin and histologically by thickening of the fascia with chronic inflammatory infiltrate containing eosinophils.
ROMANO C., RUBEGNI P., DE ALOE G., STANGHELLINI E., D'ASCENZO G., ANDREASSI L., FIMIANI M.   +6 more
openaire   +4 more sources

Treatment of chronic GVHD with extracorporeal photochemotherapy

Transfusion and Apheresis Science, 2013
The results of our center in the use of extracorporeal photopheresis in therapy of chronic GVHD are presented.
Drago Batinić, M. Lukic, B. Golubic Cepulic, Boris Labar, Sanja Perkovic, Mirela Raos, Klara Dubravčić, R. Serventi Seiwerth, Mirna Golemovic, Sanja Mazić, Ines Bojanić, Fini Plenković   +11 more
openaire   +4 more sources

EXTRACORPOREAL PHOTOCHEMOTHERAPY IN PROGRESSIVE SYSTEMIC SCLEROSIS

International Journal of Dermatology, 1993
Abstract Background. Extracorporeal photochemotherapy, an immune‐modulating form of therapy, has been shown to be effective in the treatment of autoimmune diseases. We evaluated the effects of extracorporeal photochemotherapy in the treatment of patients with progressive systemic sclerosis (pss). Methods.
F X Di Spaltro, Dwight A. Scarborough, E Degnan, Carolyn Cottrill, Albert S. Klainer, Emil Bisaccia, G J Mulford, C Cahill, A J Franks   +8 more
openaire   +3 more sources

Extracorporeal photochemotherapy

Journal of Dermatological Science, 2009
Although extracorporeal photochemotherapy (ECP) is reported to be effective for a wide variety of diseases, such as cutaneous T cell lymphoma, autoimmune diseases, organ graft rejection, and graft versus host disease, its mechanism of action remains unclear. The basis of extracorporeal photopheresis is the reinfusion of leukocytes previously exposed to
openaire   +2 more sources

Treatment of Sézary syndrome with extracorporeal photochemotherapy

Transfusion Science, 1994
In the 1980s Edelson et al.’ developed a technique for the extracorporeal irradiation of peripheral blood leucocytes with Smethoxypsoralen and showed that this markedly reduced the viability of irradiated cells. The results of a multicentre trial involving the treatment of 41 patients with cutaneous T-cell lymphoma were published in 1987.
Sean Whittaker, A. Hamblin, D. Mitchell, Margaret F Spittle, N.P. Smith, Yin Lu Ng, L. Mountford   +6 more
openaire   +3 more sources

Mechanisms of action of extracorporeal photochemotherapy

Transfusion and Apheresis Science, 2003
Extracorporeal photochemotherapy (ECP) has been shown to be effective in variety of pathologic diseases such as Sezary syndrome, autoimmune diseases, organ graft rejection and graft versus host disease. However, its mechanism of action has remained elusive.
openaire   +3 more sources

Extracorporeal photochemotherapy – the Columbia Presbyterian experience

Photodermatology, Photoimmunology & Photomedicine, 2002
Background:Cutaneous T Cell Lymphoma (CTCL) is a lymphoma of skin homing usually CD4  +  lymphocytes. There are numerous treatments available both for the early as well as the more advanced stages of the disease. Extracorporeal photochemotherapy is a well‐accepted form of treating CTCL.
Julian Mackay, Carolyn Cocco, Barbara Miller, Ingrid Warmuth, Elizabeth Knobler   +4 more
openaire   +3 more sources

Extracorporeal photochemotherapy: A scientific overview

Transfusion Science, 1994
Extracorporeal photochemotherapy was developed for treatment of cutaneous T-cell lymphoma (CTCL). Several independent and multicenter trials using lymphapheresis with 8-methoxypsoralen (8-MOP) activated by shortwave ultraviolet light have demonstrated the clinical benefit of this modality for treatment of advanced CTCL.
openaire   +3 more sources